MyFinsight
Home
Blog
About
Contact
Net gain applicable
to common...
-$4,214,875
(56.62%↑ Y/Y)
Net gain
-$4,214,875
(50.68%↑ Y/Y)
Change in fair value of
series d derivative...
-$3,955,778
Change in fair value of
series e derivative...
-$2,072,590
Change in fair value of
contingent warrant...
-$1,612
(-116.46%↓ Y/Y)
Gain before income
taxes
-$4,214,875
(50.68%↑ Y/Y)
Total other income
(loss)
$6,010,926
(49.34%↑ Y/Y)
Other income (loss)
-$16,810
(-213.44%↓ Y/Y)
Interest expense
$2,244
(-99.00%↓ Y/Y)
Loss from operations
-$10,225,801
(18.65%↑ Y/Y)
Total operating
expenses
$10,224,146
(-18.96%↓ Y/Y)
Gross profit
-$1,655
(-103.61%↓ Y/Y)
Revenue
$21,457
(-78.89%↓ Y/Y)
Impairment of goodwill
$8,134,000
(-25.50%↓ Y/Y)
Selling, general, and
administrative
$2,039,328
(21.81%↑ Y/Y)
Research and development
$50,818
(107.80%↑ Y/Y)
Cost of revenue
$23,112
(-58.58%↓ Y/Y)
Back
Back
Income Statement
Onconetix, Inc. (ONCO)
Onconetix, Inc. (ONCO)
source: myfinsight.com